A molecular and preclinical comparison of the PD-1–targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab

出版年份 2017 全文链接

标题

作者

关键词

Nivolumab, Pembrolizumab, PD-1, T-cell checkpoint

出版物

Volume 44, Issue 2, Pages 136-140

出版商

Elsevier BV

发表日期

2017-07-05

DOI

10.1053/j.seminoncol.2017.06.002

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation